Phase III trial of RP101
Latest Information Update: 02 Sep 2020
At a glance
- Drugs RP 101-Redwood Pharma (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 02 Sep 2020 New trial record
- 28 Aug 2020 According to a Redwood Pharma media release, production of more test material and additional tests including compatibility with contact lenses and toxicology will be needed to begin phase III development and the company is actively preparing for these tests.